Clinical DevelopmentLast reviewed April 2026

Master Protocol(Master Protocol)

A single overarching clinical trial protocol designed to evaluate multiple therapies, multiple indications, or multiple populations in a coordinated framework.

Usage Examples

The platform master protocol enabled rapid evaluation of multiple COVID-19 therapeutic candidates with a shared control arm.
A basket trial under one master protocol tested the targeted therapy across four tumor types harboring the same mutation.

What is Master Protocol?

Master protocols are clinical trial designs that use one shared protocol and operational infrastructure to evaluate multiple investigational products, multiple diseases/populations, or both. FDA's 2018 guidance on master protocols encourages their use where they can accelerate development and reduce costs compared to traditional sequential single-product trials.

Three main types: basket trials (one therapy, multiple indications — typically driven by a shared molecular target), umbrella trials (multiple therapies, one indication — often with patient assignment by biomarker), and platform trials (multiple therapies, single or multiple indications, with ongoing arm additions or terminations based on emerging data). Master protocols enable adaptive designs, shared control arms, and statistical efficiencies but require sophisticated operational and analytical infrastructure.

Regulatory Context

This term appears most often in clinical development workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside ICH E9, FDA GUIDANCE MASTER PROTOCOLS.

FDAEMAPMDA

When This Matters

The platform master protocol enabled rapid evaluation of multiple COVID-19 therapeutic candidates with a shared control arm.
A basket trial under one master protocol tested the targeted therapy across four tumor types harboring the same mutation.

Common Mistakes

Applying one-region clinical assumptions to global submission strategies.
Missing protocol-to-regulation traceability for pivotal studies.
Underestimating how regional guidance updates impact trial documentation.

Related Regulations

ICH E9FDA GUIDANCE MASTER PROTOCOLS

Frequently Asked Questions

Basket: one therapy tested across multiple indications sharing a molecular target. Umbrella: multiple therapies tested against one disease, often biomarker-stratified. Platform: multiple therapies evaluated with adaptive arm additions/terminations over time, often with shared control.

Master protocols often operate under multiple INDs — one per investigational product — coordinated through a shared operational framework. Some use a single "umbrella" IND covering multiple products. The specific structure depends on product ownership and FDA discussion.

Complexity of operational coordination, biostatistical requirements for multiple comparisons and adaptive elements, data management across arms with different lifecycles, and regulatory coordination across multiple sponsors or collaborators. FDA Type B meetings are strongly recommended for master protocol planning.